Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soheila Dolatabadi

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Scientific Reports|March 24, 2017
Global preamplification simplifies targeted mRNA quantificationThomas Kroneis, Emma Jonasson, Daniel Andersson, et al.
Cells|March 25, 2020
Total mRNA Quantification in Single Cells: Sarcoma Cell HeterogeneityEmma Jonasson, Lisa Andersson, Soheila Dolatabadi, et al.
Frontiers in Oncology|February 21, 2022
FUS-DDIT3 Fusion Oncoprotein Expression Affects JAK-STAT Signaling in Myxoid LiposarcomaSoheila Dolatabadi, Emma Jonasson, Lisa Andersson, et al.
The Journal of Pathology|February 12, 2016
Regulatory mechanisms, expression levels and proliferation effects of the FUS-DDIT3 fusion oncogene in liposarcomaPierre Åman, Soheila Dolatabadi, David Svec, et al.
Biomedicines|March 25, 2022
Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In VivoChristoffer Vannas, Lisa Andersson, Soheila Dolatabadi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 29, 2018
Identification of inhibitors regulating cell proliferation and FUS-DDIT3 expression in myxoid liposarcoma using combined DNA, mRNA, and protein analysesDavid Svec, Soheila Dolatabadi, Christer Thomsen, et al.
Frontiers in Genetics|February 10, 2017
Cell Cycle and Cell Size Dependent Gene Expression Reveals Distinct Subpopulations at Single-Cell LevelSoheila Dolatabadi, Julián Candia, Nina Akrap, et al.
Plos One|November 14, 2014
Normal and functional TP53 in genetically stable myxoid/round cell liposarcomaAnders Ståhlberg, Christina Kåbjörn Gustafsson, Katarina Engtröm, et al.
International Journal of Cancer|January 17, 2019
JAK-STAT signalling controls cancer stem cell properties including chemotherapy resistance in myxoid liposarcomaSoheila Dolatabadi, Emma Jonasson, Malin Lindén, et al.
EMBO Reports|April 10, 2019
FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complexMalin Lindén, Christer Thomsen, Pernilla Grundevik, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Scientific Reports|March 24, 2017
Global preamplification simplifies targeted mRNA quantificationThomas Kroneis, Emma Jonasson, Daniel Andersson, et al.
Cells|March 25, 2020
Total mRNA Quantification in Single Cells: Sarcoma Cell HeterogeneityEmma Jonasson, Lisa Andersson, Soheila Dolatabadi, et al.
Frontiers in Oncology|February 21, 2022
FUS-DDIT3 Fusion Oncoprotein Expression Affects JAK-STAT Signaling in Myxoid LiposarcomaSoheila Dolatabadi, Emma Jonasson, Lisa Andersson, et al.
The Journal of Pathology|February 12, 2016
Regulatory mechanisms, expression levels and proliferation effects of the FUS-DDIT3 fusion oncogene in liposarcomaPierre Åman, Soheila Dolatabadi, David Svec, et al.
Biomedicines|March 25, 2022
Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In VivoChristoffer Vannas, Lisa Andersson, Soheila Dolatabadi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 29, 2018
Identification of inhibitors regulating cell proliferation and FUS-DDIT3 expression in myxoid liposarcoma using combined DNA, mRNA, and protein analysesDavid Svec, Soheila Dolatabadi, Christer Thomsen, et al.
Frontiers in Genetics|February 10, 2017
Cell Cycle and Cell Size Dependent Gene Expression Reveals Distinct Subpopulations at Single-Cell LevelSoheila Dolatabadi, Julián Candia, Nina Akrap, et al.
Plos One|November 14, 2014
Normal and functional TP53 in genetically stable myxoid/round cell liposarcomaAnders Ståhlberg, Christina Kåbjörn Gustafsson, Katarina Engtröm, et al.
International Journal of Cancer|January 17, 2019
JAK-STAT signalling controls cancer stem cell properties including chemotherapy resistance in myxoid liposarcomaSoheila Dolatabadi, Emma Jonasson, Malin Lindén, et al.
EMBO Reports|April 10, 2019
FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complexMalin Lindén, Christer Thomsen, Pernilla Grundevik, et al.
Pageof 2